Ketamine vs. Spravato: What Is the Difference?
· Updated November 2026 · Aazaz Haq, MD
One question comes up in almost every consultation I do: what is the difference between Spravato and ketamine, and which one should I get? It is a good question, and the honest answer is more interesting than most ads suggest.
The short answer
Spravato contains esketamine, one half of the ketamine molecule, and is FDA-approved and usually covered by insurance. IV and IM ketamine are off-label and self-pay, and IV may work somewhat faster in observational studies. Both are given in a monitored clinic. The right choice depends on coverage, urgency, medical history and how you tolerate the experience.
Two hands of the same molecule
Ketamine comes in two mirror-image forms, like your left and right hands. The ketamine used in hospitals is a 50/50 mix of both. Esketamine, the medicine in Spravato, is one of those two hands, separated out. It binds more strongly to the brain receptor both forms act on.
Why Spravato exists at all
Ketamine was approved as an anesthetic in 1970. By the time researchers discovered, around 2000, that it could rapidly relieve depression, it was a generic drug. No company could recover the cost of large FDA trials for an inexpensive generic. So IV ketamine is still used off-label for depression, despite decades of research behind it.
Esketamine was developed as a nasal spray and went through the full FDA process for depression. That is the main reason it is usually easier to get covered by insurance.
How each is given
- IV ketamine is a slow drip over about 40 minutes, dosed by body weight. We can slow it down if the experience gets too intense.
- Intramuscular (IM) ketamine is a shot, usually in the shoulder. It comes on faster because it is absorbed all at once.
- Spravato is a nasal spray you give yourself in our clinic, in fixed doses of 56 or 84 mg.
In my experience, most people find IV and IM ketamine more intense than Spravato. That intensity does not tell you whether it is working.
Which works better?
Based on the comparative evidence available, which is almost entirely observational, IV ketamine and esketamine show similar response and remission rates, though IV ketamine may act faster. In a 2025 study of 153 patients at a Harvard-affiliated hospital, depression scores fell by about 49% with IV ketamine by the eighth treatment, compared with about 40% with esketamine. Patients were not randomly assigned, so it does not settle the question. Randomized trials are still needed.
Visit length and driving
With Spravato, federal safety rules require monitoring in the clinic for at least two hours. With IV ketamine, we discharge you when you are clinically ready, often after an hour to an hour and a half. Either way, someone needs to take you home, and with Spravato you should not drive until the next day after a full night's sleep.
Cost and insurance
Spravato is covered by most major plans, including Medicare, Virginia Medicaid and Tricare, usually with prior authorization. Ketamine for depression is almost always self-pay. At our clinic, IV or IM ketamine is $400 per treatment, and we offer payment plans. Our insurance team tells you your expected costs before you start.
What about at-home ketamine?
I am very conservative about it. The FDA has warned that compounded ketamine used at home carries added risk because no health care provider is there to monitor for serious problems. In my view, ketamine treatment is safest in a supervised medical setting, and that is how we practice.
So which is right for you?
It depends on your insurance, how quickly you need relief, how you tolerate the experience, and your medical history. Our side-by-side comparison lays out the differences visually. If you would like to talk it through, request a consultation call.
Questions I hear often
Can I switch from one to the other?
Yes. People sometimes start with Spravato because insurance covers it and move to IV ketamine if the response is partial, or the other way around if cost becomes a problem. A partial response to one is useful information when choosing the next step.
Is one safer than the other?
Both have similar side effects: dissociation, nausea, sleepiness and a temporary rise in blood pressure, mostly on treatment day. Spravato has a required two-hour monitoring period by federal rule. IV ketamine is dosed by body weight and can be slowed during the infusion. In a monitored clinic, both are generally well tolerated.
How many treatments will I need?
Both usually start with a series: twice a week for about four weeks. People who respond then move to maintenance, often weekly or every other week, and we try to space treatments as far apart as possible while keeping you well. For some people, maintenance continues for months or longer.
What I look at when helping someone choose
- Insurance coverage, since cost affects whether someone can complete a full course.
- How urgently relief is needed.
- Blood pressure, heart health and other medical conditions.
- Any history of substance use.
- How someone tolerates intense experiences, and whether they would prefer a treatment that can be slowed down.
There is rarely one right answer. The most important step is choosing a reasonable starting point and measuring carefully whether it is helping.
References
- Meisner RC, et al. Comparative effects of repeated ketamine infusion versus intranasal esketamine in patients with treatment-resistant depression: a retrospective chart review. J Clin Psychiatry. 2025. Source
- Popova V, et al. Esketamine nasal spray in treatment-resistant depression (TRANSFORM-2). Am J Psychiatry. 2019. PubMed
- Murrough JW, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013. PubMed